From owner-cardiovascular@net.bio.net Fri Aug 01 23:00:00 1997 Path: biosci!agate!newsfeed.kornet.nm.kr!howland.erols.net!newsxfer3.itd.umich.edu!oleane!jussieu.fr!univ-lyon1.fr!rockviro-2.univ-lyon1.fr!allard From: allard@cismsun.univ-lyon1.fr Newsgroups: bionet.biology.cardiovascular Subject: Re: Cardiology related Images? Date: Sat, 2 Aug 1997 11:03:02 Organization: UCBL Lines: 22 Message-ID: References: <33dc569a.5705147@nntp.z02.glo.be> NNTP-Posting-Host: rockviro-2.univ-lyon1.fr X-Newsreader: Trumpet for Windows [Version 1.0 Rev A] In article <33dc569a.5705147@nntp.z02.glo.be> gd31395@glo.be (Jean) writes: >Path: univ-lyon1.fr!news.apfel.de!howland.erols.net!news-peer.sprintlink.net!news-sea-19.sprintlink.net!news-in-west.sprintlink.net!news.sprintlink.net!Sprint!206.48.177.12!news.glo.be!not-for-mail >From: gd31395@glo.be (Jean) >Newsgroups: bionet.biology.cardiovascular >Subject: Cardiology related Images? >Date: Mon, 28 Jul 1997 09:02:12 GMT >Organization: Customer of Globe Internet NV >Lines: 8 >Message-ID: <33dc569a.5705147@nntp.z02.glo.be> >NNTP-Posting-Host: ip114.z02.glo.be >X-Newsreader: Forte Free Agent 1.1/32.230 >I'm a student. I need to prepare a seminar for my course. For that, I >would like to have some of good shemas and images (shematic >presentation of RCA or LCA, capillry, muscle, ...) for slides. If I >could know where I can find that, I will be very happy .. >Thank U. From owner-cardiovascular@net.bio.net Sun Aug 03 23:00:00 1997 Path: biosci!bloom-beacon.mit.edu!panix!howland.erols.net!ais.net!newsfeed.concentric.net!news-master!news From: "Joel Sandler" Newsgroups: bionet.biology.cardiovascular Subject: Open Heart Criteria Date: 4 Aug 1997 15:56:53 GMT Organization: Concentric Internet Services Lines: 8 Message-ID: <01bca0ef$3fcda180$3d51adce@crc3.columbia.net> Reply-To: "Joel Sandler" NNTP-Posting-Host: ts003d01.stp-fl.concentric.net X-Newsreader: Microsoft Internet News 4.70.1161 I am looking for recommended hospital criteria on Open Heart Surgery. If anyone has this information I would greatly appreciate it. -- Joel to stop spamming please respond to jsandler@concentric.net jsandler@rocketmail.com From owner-cardiovascular@net.bio.net Sun Aug 03 23:00:00 1997 Path: biosci!PUBLIC.TPT.TJ.CN!yingliu From: yingliu@PUBLIC.TPT.TJ.CN Newsgroups: bionet.biology.cardiovascular Subject: quering for information on Gene Therapy Date: 3 Aug 1997 17:27:45 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 16 Sender: daemon@net.bio.net Distribution: world Message-ID: <199708032328.IAA00510@public.tpt.tj.cn> NNTP-Posting-Host: net.bio.net Hi,colleagues I am a medical student of Medical School, NanKai University. I am now preparing to write a report on Gene Therapy. If you know any relative information on internet or in journals, such as SCIENCE, NATURE and so on, please let me know. Thank you very much in advance. yingliu medical school NanKai Univ. Tianjin,300071 P.R.China E-mail: yingliu@public.tpt.tj.cn From owner-cardiovascular@net.bio.net Sun Aug 03 23:00:00 1997 Path: biosci!agate!hammer.uoregon.edu!csulb.edu!gatech!news-out.communique.net!communique!mr.net!newsfeed.nacamar.de!europa.clark.net!206.229.87.25!news-peer.sprintlink.net!news-pull.sprintlink.net!news-in-east.sprintlink.net!news.sprintlink.net!Sprint!207.20.0.14!vncnews!newsfeed2.vnc.net!jupiter.dnai.com!castor.dnai.com!mls From: mls@cesinst.com (Mark Stevans) Newsgroups: bionet.biology.cardiovascular Subject: PowerMac cardiac activation simulator available via FTP Date: Mon, 04 Aug 1997 13:00:01 -0700 Organization: CESI Lines: 75 Message-ID: NNTP-Posting-Host: dnai-207-33-176-206.isdn.dnai.com Mime-Version: 1.0 Content-Type: text/plain; charset=ISO-8859-1 Content-Transfer-Encoding: 8bit X-Newsreader: Yet Another NewsWatcher 2.4.0 Version 2.8b0 of the CESLab cardiac electrophysiological simulation system is now available for anonymous FTP at www.cesinst.com Disclaimer: while every attempt has been made to permit the user to conduct faithful simulations of selected aspects of cardiac electrophysiology, no version of the CESLab software has yet been independently reviewed for medical accuracy. New CESLab 2.8 Features Improved accuracy of generated current dipoles. Support for conducting simulations on rectangular blocks of cells with torso modelling. Improved accuracy in compound shape modeller. New cell display modalities, including instantaneous activation wavefront. VCG simulation using the Frank or McFee lead systems. Expanded ElectroWorld viewer windows, incorporating VCG distortion viewer and selectable regional dipoles. Heart dipole graph windows. Automatically calibrated color keys. New polyhedron editor facet display modalities. Optional overlaying of traces in ECG, VCG, heart dipole scope, and heart dipole graph windows. Bugs Fixed Since Last Release (2.4b0) Bug 4: Deflections of lead V1 much greater than those of V6. Bug 5: Heart dipole displays lack of continuity between adjacent samples. Bug 11: If cell size is changed after running a simulation, no more simulations can be run. Bug 13: If a cardiac cycle is run, and resolution is changed, ECG is flat on successive runs. Bug 24: Wilson¹s central terminal is assumed to be always zero in ECG. Bug 47: Cell set viewer cutaway offset sliders won't allow the user to thumb all the way to the end of their range. Bug 136: User interface does not perform enough validation of user input. Bug 160: Command-. does not abort the current operation cleanly in all cases. Bug 177: Need to clear ECG window before beginning each cardiac cycle. Bug 180: Fencepost deletion sometimes deletes the wrong fencepost when the two are very closely spaced. Bug 193: Regional dipole locations are drawn incorrectly after restore from file. Bug 194: ECG traces are too close together. Bug 383: Formula for computing ellipsoidal conduction velocities incorrect. Please feel free to contact me via E-mail with any bugs, questions, or comments. Mark Stevans mls@cesinst.com From owner-cardiovascular@net.bio.net Sun Aug 03 23:00:00 1997 Path: biosci!agate!hammer.uoregon.edu!csulb.edu!gatech!howland.erols.net!europa.clark.net!199.60.229.3!newsfeed.direct.ca!su-news-hub1.bbnplanet.com!news.bbnplanet.com!news.pbi.net!news1.rcsntx.swbell.net!usenet From: "frazzled" Newsgroups: bionet.biology.cardiovascular Subject: Re: Open Heart Criteria Date: 4 Aug 1997 23:52:43 GMT Organization: Southwestern Bell Internet Services Lines: 18 Message-ID: <01bca110$989547c0$4102c1cf@rot> References: <01bca0ef$3fcda180$3d51adce@crc3.columbia.net> NNTP-Posting-Host: ppp-207-193-1-19.kscymo.swbell.net X-Newsreader: Microsoft Internet News 4.70.1160 http://www.geocities.com/Heartland/Hills/2571/heartlinks.htm Under Misc and Useful, click: Hospital Report Cards. -- Jon -- MrBooBoo@msn.com http://www.geocities.com/Heartland/Hills/2571/jonsitemap.htm Joel Sandler wrote in article <01bca0ef$3fcda180$3d51adce@crc3.columbia.net>... > I am looking for recommended hospital criteria on Open Heart Surgery. If > anyone has this information I would greatly appreciate it. > -- > Joel > > to stop spamming please respond to > jsandler@concentric.net > jsandler@rocketmail.com > From owner-cardiovascular@net.bio.net Mon Aug 04 23:00:00 1997 From: "Joseph Cannon" Subject: ISO CV diease statistics Newsgroups: bionet.biology.cardiovascular Organization: ASPEN Personal Fitness Consultants Message-ID: <01bca158$51480680$a9f6cdce@joe-s-computer> X-Newsreader: Microsoft Internet News 4.70.1161 NNTP-Posting-Host: ascend363.nni.com Date: 5 Aug 97 03:36:14 GMT Lines: 8 Path: biosci!bloom-beacon.mit.edu!panix!howland.erols.net!news2.digex.net!news5.digex.net!news.nni.com!ascend363.nni.com does anybody have any recent journal references which tell of the statistics of CV disease in the US? Im doing a book and i would like to have some stats. please email me back if you do. thanks -- Joseph Patrick Cannon, M.S., C.S.C.S. ASPEN Personal Fitness Consultants of Pennsylvania From owner-cardiovascular@net.bio.net Mon Aug 04 23:00:00 1997 Path: biosci!agate!newsgate.duke.edu!nntprelay.mathworks.com!news.mathworks.com!uunet!in4.uu.net!207.167.64.6!news.znet.com!not-for-mail From: Claire&Dan Newsgroups: sci.med,sci.med.cardiology,bionet.biology.cardiovascular Subject: Re: Chest Pain Date: Tue, 05 Aug 1997 01:00:15 -0700 Organization: sd.znet.com Lines: 40 Message-ID: <33E6DD8F.2D3C@sd.znet.com> References: <33DFC1E0.11F2@dreamscape.com> <5rp1b1$mq7$1@nnrp2.snfc21.pbi.net> <5rq5e0$hno@mufasa.harvard.edu> <5s6a2t$kr4$1@nnrp4.snfc21.pbi.net> NNTP-Posting-Host: 207.167.66.24 Mime-Version: 1.0 Content-Type: text/plain; charset=iso-2022-jp Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.0 (Win95; I) Don C Royal DC wrote: > What I was trying to convey (and I did it very badly) is the impotance > of ruling out cardiac disease which can occur concommitantly with > anything else. It is very dissapointing to manage successfully a > musculoskeletal condition to find that suddenly, a cardiac presentation > has emerged from under the resolving musculoskeletal complaint (as far > too many of my collegues will attest). In view of the morbidity and > mortality associated with cardiac illness, I feel strongly that it must > be ruled out, not only in those with musculoskeletal conditions, but in > everyone that presents for care in the office of a portal of entry > provider. This sounds like very reasoned and experienced medical advice. But I have another question about chest pain: do you docs do automatic screening for aortic dissections as well? Probably most of you are familiar with the sad story of Jonathan Larson, playwright of Rent. He died of an aortic dissection the morning before the show was to have opened. He'd been to several hospital ERs, and no doctor discovered the life-threatening problem. Why was this? Are only EKGs and cardiac enzymes done to r/o cardiac origin of chest pain? I have personal reasons for interest in this subject. I'm a survivor of an acute dissection (at 4.1 cm), have Marfan, am a cardiac nurse, and told the paramedics and ER staff what was going on. (heck, my heart was trying to explode) And they still did not take it seriously, at first. I realize, of course, that acute aortic emergencies (or even those incidents where you have some time to plan) are less common than MIs. But they are certainly no less catastrophic. I was told by a cardiac surgeon friend that all ERs should be equipped with TEE capability, done on the spot. I had to wait almost 8 hours from the time I was wheeled in the ER door to the time of surgery. (things did happen rather more quickly after my CT scan, but then, it's a miracle I even survived that long) Hope that there are some opinions and explanations out there. Claire K. From owner-cardiovascular@net.bio.net Mon Aug 04 23:00:00 1997 Path: biosci!agate!newsgate.duke.edu!nntprelay.mathworks.com!news.maxwell.syr.edu!news.pbi.net!news.pacbell.net!not-for-mail From: Don C Royal DC <"NO@SPAMdroyaldc"@pacbell.net> Newsgroups: sci.med,sci.med.cardiology,bionet.biology.cardiovascular Subject: Re: Chest Pain Date: Mon, 04 Aug 1997 21:26:15 -0700 Organization: Bayshore Medical Lines: 45 Message-ID: <5s6a2t$kr4$1@nnrp4.snfc21.pbi.net> References: <33DFC1E0.11F2@dreamscape.com> <5rp1b1$mq7$1@nnrp2.snfc21.pbi.net> <5rq5e0$hno@mufasa.harvard.edu> NNTP-Posting-Host: ppp-206-170-70-81.irvn11.pacbell.net Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 3.03Gold (Win95; I) David Rind wrote: > > In article <5rp1b1$mq7$1@nnrp2.snfc21.pbi.net>, > Don C Royal DC <"NO@SPAMdroyaldc"@pacbell.net> wrote: > >> couple weeks, I've noticed a pain below my ribcage on the left side of > >> my chest. The only time I feel this pain is if I twist my upper body to > >> my right. > >> it. > > >#1) Chest Pain is cardiac till proved otherwise. > This is not a sensible recommendation or comment. Chest pain that > occurs with change in body position in an otherwise healthy 22 year old > is certainly not "cardiac till proved otherwise." A stress test is worse > than worthless in this situation, as the rate of false positives is going > to far exceed the rate of true positives in a low-prior-probability > situation like this. Then, with a false positive result, someone > will decide that cardiac catheterization is indicated and there will > be the possibility of real harm. I did not mean to suggest this as an entry level examination but as a possible endpoint of a thorough evaluation. Obviously a thorough history will dictate intelligent evaluation. Resting ECG, Cardiac enzymes if recent MI cannot be ruled out, Isoenzymes if the cardiac enzymes are not definitve, clinical correlation with exam findings etc. > > You should not perform stress tests in people who do not have reasonable > likelihoods of coronary artery disease. There is no reason to exclude > CAD in everyone with chest pain. > -- > David Rind > rind@enterprise.bih.harvard.edu What I was trying to convey (and I did it very badly) is the impotance of ruling out cardiac disease which can occur concommitantly with anything else. It is very dissapointing to manage successfully a musculoskeletal condition to find that suddenly, a cardiac presentation has emerged from under the resolving musculoskeletal complaint (as far too many of my collegues will attest). In view of the morbidity and mortality associated with cardiac illness, I feel strongly that it must be ruled out, not only in those with musculoskeletal conditions, but in everyone that presents for care in the office of a portal of entry provider. From owner-cardiovascular@net.bio.net Mon Aug 04 23:00:00 1997 Path: biosci!agate!newsgate.duke.edu!nntprelay.mathworks.com!europa.clark.net!205.252.116.205!howland.erols.net!gatech!purdue!oitnews.harvard.edu!enterprise.bidmc.harvard.edu!rind From: rind@enterprise.bidmc.harvard.edu (David Rind) Newsgroups: sci.med,sci.med.cardiology,bionet.biology.cardiovascular Subject: Re: Chest Pain Date: 5 Aug 1997 20:08:56 GMT Organization: Center for Clinical Computing, Beth Israel Hospital, Boston, MA Lines: 27 Message-ID: <5s818o$rpu@mufasa.harvard.edu> References: <33DFC1E0.11F2@dreamscape.com> <5rq5e0$hno@mufasa.harvard.edu> <5s6a2t$kr4$1@nnrp4.snfc21.pbi.net> <33E6DD8F.2D3C@sd.znet.com> NNTP-Posting-Host: enterprise.bidmc.harvard.edu In article <33E6DD8F.2D3C@sd.znet.com>, Claire&Dan wrote: >This sounds like very reasoned and experienced medical advice. But I >have another question about chest pain: do you docs do automatic >screening for aortic dissections as well? Probably most of you are >familiar with the sad story of Jonathan Larson, playwright of Rent. He >died of an aortic dissection the morning before the show was to have >opened. He'd been to several hospital ERs, and no doctor discovered the >life-threatening problem. Why was this? Are only EKGs and cardiac Most of the doctors I know are real glad they weren't working in any of those ERs when he came in. Figuring out that chest pain in a man in his 30s without known Marfan's is an aortic dissection would be really tricky. Even in an older person with known longstanding hypertension it can be a hard diagnosis to make. It is also, of course, an absolutely imperative diagnosis to make, which is what makes it such a scary disease for doctors. There is no way that everyone who ever comes to an ER with unexplained chest pain can have an MRA or a cine-angio or a TEE, so doctors have to use clinical judgement in figuring out who might have a dissection. Fairly often they fail at this, unfortunately. Keeping it in mind, though, is probably the most important part of making the diagnosis. -- David Rind rind@enterprise.bih.harvard.edu From owner-cardiovascular@net.bio.net Tue Aug 05 23:00:00 1997 Path: biosci!agate!howland.erols.net!infeed1.internetmci.com!newsfeed.internetmci.com!newsfeed.direct.ca!news.he.net!news.onramp.net!newshost.cyberramp.net!nntp.flash.net!excalibur.flash.net!not-for-mail From: "J. Robert Hobgood" Newsgroups: sci.med,sci.med.cardiology,bionet.biology.cardiovascular Subject: Re: Chest Pain Date: Tue, 05 Aug 1997 08:07:03 -0500 Organization: Flashnet Communications, http://www.flash.net Lines: 18 Message-ID: <33E72574.B6D1B9AB@flash.net> References: <33DFC1E0.11F2@dreamscape.com> <5rp1b1$mq7$1@nnrp2.snfc21.pbi.net> <5rq5e0$hno@mufasa.harvard.edu> <5s6a2t$kr4$1@nnrp4.snfc21.pbi.net> NNTP-Posting-Host: hsh6-83.flash.net Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 4.01 [en] (Win95; U) To: Don C Royal DC <"NO@SPAMdroyaldc"@pacbell.net> X-Priority: 3 (Normal) Permit me a word on the importance of ruling out cardiac disease which can occur concommitantly with anything else. A doctor's knowledge is of considerable importance in the process but so too is the doctor's thinking. I believe that the doctor ought to think out loud so the patient can know what is happening inside his doctor's head. Perhaps if doctors could recognize remote possibilities when they saw them, doctors could feel more at ease in keeping their thinking to themselves. The problem is that articulation helps the doctor to think, and frequently thinking, not knowledge, is the critical aspect of the process. Remote possibilities? Remote possibilities are remote until the patient dies and the doctor is sued for malpractice. Then the doctor with a duty to inform the patient is faced with his failure to inform the patient of the risks the doctor was taking with his patient's life. From owner-cardiovascular@net.bio.net Thu Aug 07 23:00:00 1997 Path: biosci!bloom-beacon.mit.edu!panix!howland.erols.net!portc02.blue.aol.com!audrey01.news.aol.com!not-for-mail From: eyedocjx@aol.com (Eyedocjx) Newsgroups: bionet.biology.cardiovascular Subject: 20 year old annuloplasty Date: 8 Aug 1997 13:59:11 GMT Lines: 11 Message-ID: <19970808135900.JAA28046@ladder01.news.aol.com> NNTP-Posting-Host: ladder01.news.aol.com X-Admin: news@aol.com Organization: AOL http://www.aol.com My wife had a Charpentier annuloplasty ring done by D. Cooley in the 70's . I am wondering if she should be on any kind of registery ...for followup. Her current cardiologist has never mentioned this. She has regular checkups and has some leakage (mitral)...but noone seems to get very excited about her findings on echo. Questions: are these rings done any more? what is long term survival ? How to get in touch with Dr. Cooley's people...or those in charge of follow up on his cases? Thank you Boyd Clark. From owner-cardiovascular@net.bio.net Sun Aug 10 23:00:00 1997 Path: biosci!agate!spool.mu.edu!uwm.edu!vixen.cso.uiuc.edu!news-peer.sprintlink.net!news.sprintlink.net!Sprint!news.maxwell.syr.edu!news.webspan.net!newsfeeds.sol.net!newsspool.sol.net!munnari.OZ.AU!harbinger.cc.monash.edu.au!news.cs.su.oz.au!inferno.mpx.com.au!peg.apc.org!news.bri.connect.com.au!news.syd.connect.com.au!news.mel.connect.com.au!not-for-mail From: "John G King" Newsgroups: alt.image.medical,bionet.biology.cardiovascular,fj.sci.medical,misc.education.medical,sci.med.cardiology Subject: Cardiology, Phrenic Nerve Damage Date: Sun, 10 Aug 1997 13:54:19 +1000 Organization: J G King Pty Ltd Lines: 6 Message-ID: <5sjdmb$n9e$1@perki.connect.com.au> NNTP-Posting-Host: acc3-ppp49.mel.interconnect.com.au X-Newsreader: Microsoft Outlook Express 4.71.1008.3 X-MimeOle: Produced By Microsoft MimeOLE Engine V4.71.1008.3 I am a post grad nurse in cardiology. I am preparing a paper on phrenic nerve damage during CAGS. I would greatly appreciate any help in this area. From owner-cardiovascular@net.bio.net Sun Aug 10 23:00:00 1997 Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!news.apfel.de!chico.franken.de!news-nue1.dfn.de!wuff.mayn.de!fu-berlin.de!news.th-darmstadt.de!News.Uni-Marburg.DE!not-for-mail From: JaoHan Newsgroups: bionet.biology.cardiovascular Subject: Ph.D. Date: 10 Aug 1997 09:34:02 GMT Organization: HRZ Uni Marburg Lines: 36 Message-ID: <33ED8D33.613C@mailer.uni-marburg.de> Reply-To: yao@maier.uni-marburg.de NNTP-Posting-Host: pcmp169.mpi.uni-marburg.de Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 3.01 (Win95; I) Postdoctoral Research Fellowship in Molecular Biology The project is funded by the TMR (Training and Mobility of Researchers) and therefore addresses to young scientists who are members of countries of the European Union. It involves the molecular analysis of Bradyrhizobium japonicum signal peptidases and their roles in the establishment and maintenance of symbiotic interactions with soybeans and other host plants. The main goal of the project will be to analyze the function of several newly identified genes of B. japonicum and to study the influence of bacterial mutations on the host plant. Applicants should have good knowledges in molecular genetics, gene expression techniques, protein biochemistry and immunology. Salary (tax free grant) will be up to DM 36,000.- per annum, and the post is available immedeately for a period of two years. Informal enquiries may be made to Dr Peter Müller Fax.: 0049 6421 28 8997 Tel.: 0049 6421 28 2072 e-mail: muellerp@nws.biologie.uni-marburg.de Further information and details of how to apply may be obtained from Prof. Dr. D. Werner Philipps University of Marburg Dept. of Biology/Botany Karl-von-Frisch-Straße 35032 Marburg Germany From owner-cardiovascular@net.bio.net Sun Aug 10 23:00:00 1997 Path: biosci!news.Stanford.EDU!su-news-hub1.bbnplanet.com!cam-news-hub1.bbnplanet.com!news.bbnplanet.com!news-feed1.tiac.net!posterchild!news@tiac.net From: jamesl@healthtech.com (James W. Larkin) Newsgroups: bionet.biology.cardiovascular Subject: REACTIVE OXYGEN: New Therapeutics and Applications Date: 11 Aug 1997 18:47:42 GMT Organization: Cambridge Healthtech Institute Lines: 199 Message-ID: <5snmoe$7nb@news-central.tiac.net> NNTP-Posting-Host: 207.60.238.8 Mime-Version: 1.0 Content-Type: Text/Plain; charset=ISO-8859-1 X-Newsreader: WinVN 0.99.9 Beta 1 (x86 32bit) REACTIVE OXYGEN: New Therapeutics and Applications Sept. 25-26, 1997 The Ritz-Carlton, McLean, Virginia Overview Therapeutic Antioxidants: Rational Approaches to a Radical Problem Dr. Craig E. Thomas, Eli Lilly and Company Ischemia/Reperfusion Phospholipid Oxidation and Remodeling During Early Ischemia Reperfusion Injury: Studies Using an Endothelial Cell Culture Model System Dr. Alex Sevanian, University of Southern California Regulation of Neutrophil Inflammatory Activity in Vitro and in Vivo by Dehydroepiandrosterone (DHEA) Dr. Barbara Araneo, Pharmadigm, Inc. New Agent, Imidate, Provides Protection Against Ischemia Reperfusion Injury Dr. Howard L. Elford, Molecules for Health, Inc. Restenosis and Atherosclerosis Pro-oxidant Effects of Antioxidants: Novel Implications in Atherosclerosis Dr. Sampath Parthasarathy, Emory University Reactive Oxygen and Atherosclerosis Amylin Pharmaceuticals, Inc. (invited) Title to Be Announced Dr. Pat Killian, gene/Networks (invited) ARDS and Related Respiratory Disorders OTZ in Patients with ARDS Dr. Hector Gomez, Transcend Therapeutics, Inc. Salen Manganese Complexes: Combined Superoxide Dismutase/ Catalase Mimics with Potential Therapeutic Utility in ARDS Dr. Susan R. Doctrow, Eukarion, Inc. Vantox: A Novel Antioxidant for the Treatment of Respiratory Conditions Dr. Sheldon S. Hendler, Vyrex Corporation Inflammation and Related Applications Glutathione Peroxidase (GPx) Mimics in the Treatment of Diseases Associated with Oxidative Stress Dr. Timothy C. Rodell, OXIS International, Inc. Oxidants, NFKB, and Chronic Inflammation Dr. Matthew B. Grisham, Louisiana State University Prevention of Muscle Wasting of Cachexia by Inhibitors of Nitric Oxide Synthesis and Antioxidants Dr. Mario Chojkier, University of California, San Diego Reactive Oxygen Signaling in the Liver Dr. William E.M. Lands, National Institutes of Health New Hypocholesterolemic Organosilanes with Antioxidant Properties Dr. Serge Halazy, Institut de Recherche Pierre Fabre Aging and Neurodegenerative Disorders Mapping Reactive Oxygen-Induced DNA Damage at Nucleotide Resolution Dr. Steven A. Akman, Wake Forest University A Cellular Receptor for Amyloid-beta Peptide: From Neurons to Microglia with RAGE Dr. Shi Du Yan, Columbia University Free Radicals in the Vasoactivity and Cytotoxicity of b-Amyloid Peptides Dr. Michael J. Mullan, University of South Florida Recent Advances in the Mitochondrial Etiology of Neurodegenerative Diseases, Including Parkinson’s and Alzheimer’s Dr. James A. Dykens, Mitokor Cambridge Healthtech Institute’s REACTIVE OXYGEN: New Therapeutics and Applications September 25-26, 1997 The Ritz-Carlton, McLean, Virginia Reactive oxygen is a necessary by-product of numerous cellular processes, from which the body protects itself with various antioxidant strategies. When these protections fail or are overwhelmed, the damage to tissue, cells, and genes can be extensive. Indications for which antioxidant therapeutics may be useful include cardiovascular disorders such as atherosclerosis and restenosis; ischemia/reperfusion injury from stroke, heart attack, or other sources; ARDS and other respiratory conditions; aging and neurodegenerative diseases; certain autoimmune disorders; infections; cachexia; and others. Among the therapeutic approaches that will be discussed are versions and mimetics of superoxide dismutase and other enzymes, stimulation of glutathione production, and other radical scavengers, particularly small molecules. HOTEL INFORMATION T: 703-506-4300 The Ritz-Carlton, Tysons Corner F: 703-506-2694 1700 Tysons Blvd. Cut-off Date: September 3, 1997 McLean, VA 22102 Room Rate: $135 Single/Double Reservations made after the cut-off date will be accepted on a space-and-rate-availability basis. Available rooms are limited, so please book early. Please identify yourself as a Cambridge Healthtech Institute conference attendee to receive the reduced room rate. TRAVEL INFORMATION Travelworld T: 717-288-9311 or 800-828-6033 601 Market Street F: 717-288-4693 Kingston, PA 18704 Exclusive airline discounts are available on American Airlines as well as other specific airlines when tickets are purchased through Travelworld at least 14 days prior to the meeting date. Some restrictions apply. CALL FOR POSTERS Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. Please fill out the registration form, with the poster title and primary author. To ensure inclusion in the conference binder, a one-page summary must be submitted by September 19, 1997. CALL FOR EXHIBITORS Space is available for companies interested in exhibiting products and services related to oxygen radicals. This meeting should attract up to several hundred senior researchers and managers representing a broad range of disciplines and perspectives. Please contact Jim MacNeil of Cambridge Healthtech Institute at 617-630-1341 to obtain an exhibitor package or to inquire about offering a workshop during the meeting. Exhibit space is limited so call now to reserve a space at this premier event. Each registration includes all conference sessions, posters and exhibits, one luncheon and reception, continental breakfasts, all refreshment breaks, and a copy of the document binder. A group rate is available for three or more people from the same organization. Call for more details. Handicapped Equal Access: In accordance with the ADA, Cambridge Healthtech Institute is pleased to arrange for special accommodations for attendees with special needs. All requests for such assistance must be submitted in writing to CHI at least 30 days prior to the start of the meeting. Substitution/Cancellation Policy In the event that you need to cancel a registration you may: – Transfer your registration to a colleague within your organization - Credit your registration to another Cambridge Healthtech Institute program – Request a refund minus a $75 processing fee – Request a refund minus the cost ($150) of ordering a copy of the document binder Cancellations will only be accepted up to one week prior to the conference. ----------------------Cut and print here.------------------------ Yes! |__| Please register me for REACTIVE OXYGEN 577E Academic, Government, Commercial Hospital-Affiliated Advance Registration |__| $795 |__| $395 (by August 15, 1997) On-site or Late Registration |__| $895 |__| $445 FIRST NAME:______________________LAST NAME:__________________________ TITLE: __________________________DIV./DEPT.:_________________________ COMPANY:_____________________________________________________________ ADDRESS:_____________________________________________________________ CITY/STATE/ZIP: ______________________COUNTRY:_______________________ TELEPHONE:____________________________FAX:___________________________ E-MAIL:______________________________________________________________ |__| Please send information on exhibiting and opportunities to present workshops. |__| Enclosed is a check or money order payable to Cambridge Healthtech Institute, drawn on a U.S. bank, in U.S. currency. |__| Please charge: |__| AMEX (15 digits) |__| Visa (13 to 16 digits) |__| MasterCard (16 digits) CARD #:______________________________________________________________ EXP. DATE:___________________________________________________________ CARDHOLDER’S NAME:___________________________________________________ SIGNATURE:___________________________________________________________ CARDHOLDER’S ADDRESS (if different from above):______________________ _____________________________________________________________________ |__| Reserve with credit card information listed above and invoice me. (Invoices must be paid in full by the deadline to retain registration discount. Invoices unpaid one week prior to conference will be billed to credit card at full registration rate.) If you plan to register on site, please check with CHI beforehand for space availability. |__| I am interested in presenting a poster at REACTIVE OXYGEN: New Therapeutics & Applications and will provide an abstract by September 19, 1997. Poster title:________________________________________________________ _____________________________________________________________________ FAX or MAIL your registration to: Cambridge Healthtech Institute 1037 Chestnut Street Newton Upper Falls, MA 02164 tel: 617-630-1300 fax: 617-630-1325 From owner-cardiovascular@net.bio.net Tue Aug 12 23:00:00 1997 Path: biosci!agate!howland.erols.net!infeed1.internetmci.com!newsfeed.internetmci.com!204.71.0.47!news.internetMCI.com!not-for-mail From: "LPB" Newsgroups: bionet.biology.cardiovascular Subject: A Healthcare Directory on the Internet Date: 13 Aug 1997 19:52:26 GMT Organization: Internet MCI Lines: 7 Message-ID: <01bca810$cab78860$891437a6@default> NNTP-Posting-Host: usr7-dialup9.mix1.bloomington.mci.net X-Newsreader: Microsoft Internet News 4.70.1161 The Medical Access Online healthcare directory is the first completely integrated medical information provider online. This dynamic site has 1000's of links to doctors, hospitals, insurance companies, pharmaceutical companies, and more. New sites are added daily to provide you the most updated medical resource available on the Internet. Surf our site at http://www.medical-access.com From owner-cardiovascular@net.bio.net Wed Aug 13 23:00:00 1997 Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!infeed1.internetmci.com!newsfeed.internetmci.com!205.185.79.4!zdc!super.zippo.com!lotsanews.com!news1.rcsntx.swbell.net!usenet From: "frazzled" Newsgroups: bionet.biology.cardiovascular Subject: congestive heart failure Date: 14 Aug 1997 05:29:38 GMT Organization: Southwestern Bell Internet Services Lines: 22 Message-ID: <01bca873$6344f420$0a01c1cf@rot> NNTP-Posting-Host: ppp-207-193-1-10.kscymo.swbell.net X-Newsreader: Microsoft Internet News 4.70.1160 Hi, http://www.geocities.com/Heartland/Hills/2571/jonsplace.htm This is a support and information forum for those with congestive heart failure and those who's loved one has CHF. Message boards, chat room, medical studies, drug trials, carefully selected WWW links and CHF from patients' perspectives. Also includes information on and discussion of minerals, vitamins, nutrients, alternative therapies, surgeries and doctors. I have CHF (EF=13%), and maintain the site. Everyone interested in CHF is welcome, including doctors, nurses and other medical professionals, but this is a non-commercial site and is geared to people with the condition or those whose loved one has CHF. A site index is located at the URL in my signature. Thanks, -- Jon -- MrBooBoo@msn.com http://www.geocities.com/Heartland/Hills/2571/jonsitemap.htm -- Jon -- MrBooBoo@msn.com http://www.geocities.com/Heartland/Hills/2571/jonsitemap.htm From owner-cardiovascular@net.bio.net Thu Aug 14 23:00:00 1997 From: James Newman Newsgroups: alt.image.medical,alt.medical.sales.jobs.offered,alt.medical.sales.jobs.resumes,fj.sci.medical,francom.medical,misc.education.medical,tnn.medical,ucd.talk.medical.entomology,alt.fan.asprin,ntu.dep.medicine,relcom.commerce.medicine,talk.politics.medicine,tw.bbs.sci.medicine,sci.med.telemedicine,hiv.alt-treatments,soc.support.depression.treatment,bionet.biology.cardiovascular,sci.med.cardiology,alt.support-heart,alt.support.cancer,alt.support.cancer.prostate,alt.support.cancer.testicular,sci.med.diseases.cancer,sci.med.prostate.cancer,tw.bbs.star.cancer Subject: Is aspirin the best protection for heart attack? Date: Fri, 15 Aug 1997 05:10:21 -0700 Organization: RidgeNET Lines: 36 Message-ID: <33F4472C.34118E30@ridgenet.net> NNTP-Posting-Host: annex038.ridgecrest.ca.us Mime-Version: 1.0 Content-Type: multipart/alternative; boundary="------------E1C629778564AE9AD6E03093" X-Mailer: Mozilla 4.01 [en] (Win95; I) X-Priority: 3 (Normal) Path: biosci!bloom-beacon.mit.edu!yama.mcc.ac.uk!easynet-uk!news.mite.net!theplanet.net!su-news-hub1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!infeed2.internetmci.com!newsfeed.internetmci.com!199.120.150.5!news.ridgecrest.ca.us!not-for-mail --------------E1C629778564AE9AD6E03093 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Is aspirin the best protection for heart attack? For over two decades aspirin has been known to inhibit the activity of blood platelets. But is it the best on the market? For more information please contact: Mike and Connie Newman http://www.ridgenet.net/~jamesn/asprin.html Ask for free brochure. --------------E1C629778564AE9AD6E03093 Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: 7bit Is aspirin the best protection for heart attack?

For over two decades aspirin has been known to inhibit the activity of blood platelets. But is it the best on the market?

For more information please contact:  Mike and Connie Newman

http://www.ridgenet.net/~jamesn/asprin.html

Ask for free brochure.
  --------------E1C629778564AE9AD6E03093-- From owner-cardiovascular@net.bio.net Fri Aug 15 23:00:00 1997 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!news.sgi.com!nntprelay.mathworks.com!howland.erols.net!news.maxwell.syr.edu!news.bc.net!dragon.sk.sympatico.ca!canopus.cc.umanitoba.ca!roberson From: roberson@ibd.nrc.ca (Walter Roberson) Newsgroups: alt.image.medical,alt.medical.sales.jobs.offered,alt.medical.sales.jobs.resumes,fj.sci.medical,francom.medical,misc.education.medical,tnn.medical,ucd.talk.medical.entomology,alt.fan.asprin,ntu.dep.medicine,relcom.commerce.medicine,talk.politics.medicine,tw.bbs.sci.medicine,sci.med.telemedicine,hiv.alt-treatments,soc.support.depression.treatment,bionet.biology.cardiovascular,sci.med.cardiology,alt.support-heart,alt.support.cancer,alt.support.cancer.prostate,alt.support.cancer.testicular,sci.med.diseases.cancer,sci.med.prostate.cancer,tw.bbs.star.cancer Subject: Re: Is aspirin the best protection for heart attack? Date: 15 Aug 1997 23:36:11 GMT Organization: The University of Manitoba Lines: 39 Message-ID: <5t2p5b$r7o$1@canopus.cc.umanitoba.ca> References: <33F4472C.34118E30@ridgenet.net> NNTP-Posting-Host: zeno.ibd.nrc.ca In article <33F4472C.34118E30@ridgenet.net>, James Newman wrote: :Is aspirin the best protection for heart attack? :For over two decades aspirin has been known to inhibit the activity of :blood platelets. But is it the best on the market? 'Protection' in the case of heart attack includes both prevention of attacks, and reduction of tissue damage when an attack does occur. Quite a lot of research has been done into drugs and dosage schemes (i.e., how much of which drug should be taken when), and the field has advanced considerably over the last few decades. Interesting and successful new work continues to go on in the field. Mr. Newman's WWW page (http://www.ridgenet.net/~jamesn/asprin.html) refers to "a unique and revolutionary flavonoid-based dietary supplement". Good nutrition is certainly very important in reducing the risk of heart attack, but all the peer-reviewed scientific research that I am aware of suggests that the BEST ways to protect the heart involve fairly carefully balanced chemical solutions administered at relatively precise times. "Dietary supplements" might *help*, but if it were my health, I would not want to count upon them alone. I would suggest that people with interests in the matter of heart protection do some investigation, such as reading articles from The Journal Of Cardiology. Medline should find quite a number of references, including to some very solid research that we've done here at the National Research Council Canada, Institute For Biodiagnostics (http://www.ibd.nrc.ca) Walter Roberson roberson@Ibd.nrc.ca Disclaimer: I am not a doctor or medical researcher, but I do attend some of the in-house lectures that deal with this subject matter. Do not count on what I have written: check the literature yourself instead. From owner-cardiovascular@net.bio.net Fri Aug 15 23:00:00 1997 Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!howland.erols.net!rill.news.pipex.net!pipex!tank.news.pipex.net!pipex!usenet From: "Declan O'Kane" Newsgroups: bionet.biology.cardiovascular Subject: Cardiology - Please drop by my site for the best information on cardiology and heart disease on the net Date: 16 Aug 1997 01:24:41 GMT Organization: UUNet UK server (post doesn't reflect views of UUNet UK) Lines: 7 Message-ID: <01bca9e0$01280660$dff582c1@default> NNTP-Posting-Host: af223.du.pipex.com X-Trace: soap.uunet.pipex.com 871694681 26453 (None) 193.130.245.223 X-Complaints-To: news@soap.uunet.pipex.com X-Newsreader: Microsoft Internet News 4.70.1161 Cardiology - Please drop by my site for the best information on cardiology and heart disease on the net -- Dr Declan O'Kane Cardiology guide at the Mining Company http://cardiology.miningco.com "A man is what he does, not what he hides" From owner-cardiovascular@net.bio.net Fri Aug 15 23:00:00 1997 Path: biosci!agate!newsfeed.kornet.nm.kr!nntp.kreonet.re.kr!newsfeed.dacom.co.kr!newsfeed.direct.ca!portc01.blue.aol.com!audrey02.news.aol.com!not-for-mail From: huntpharm@aol.com (Huntpharm) Newsgroups: bionet.biology.cardiovascular Subject: US-NC-HEAD OF DEPT. X-RAY CRYSTALLOGRAPHY BACKGROUND Date: 16 Aug 1997 18:55:46 GMT Lines: 13 Message-ID: <19970816185500.OAA14481@ladder02.news.aol.com> NNTP-Posting-Host: ladder02.news.aol.com X-Admin: news@aol.com Organization: AOL http://www.aol.com I am looking for a PhD Scientist to be the Head of the Department of Structural Chemistry. The candidate will have a strong background in either X-Ray Crystallography or Computational Chemistry . As the person in this visionary role, you will be responsible for leading a group of sixteen scientists and growing. You should possess a PhD with 5+ years experience and strong publication record. We are a leading pharmaceutical company with research facilities in North Carolina and can provide excellent benefits (health insurance, dental, and vision plan, bonus program, paid vactation and more). Excellent compensation package. A high impact, high profile position with excellent opportunity for advancement. Please contact Scott Shanes by phone at 609-584-8733 Ext. 218, fax CV and cover letter to 609-584-9575 or E-Mail to sis@diedremoire.com From owner-cardiovascular@net.bio.net Sat Aug 16 23:00:00 1997 Path: biosci!agate!newsfeed.kornet.nm.kr!howland.erols.net!infeed2.internetmci.com!newsfeed.internetmci.com!169.132.11.200!news.idt.net!nntp.farm.idt.net!news From: rsl12919@mail.idt.net Newsgroups: bionet.biology.cardiovascular Subject: Factor V Gene Mutation Date: Sun, 17 Aug 1997 00:52:56 -0700 Organization: IDT Lines: 6 Message-ID: NNTP-Posting-Host: ip118.colorado-springs.co.pub-ip.psi.net X-Newsreader: MicroPlanet Gravity v1.01 Last December I was hospitalized for a week with Deep Venous Thrombosis (DVT). Recent blood tests showed I have the Factor V gene mutation which promotes clotting. Are there known treatments to help minimize the reoccurance of getting another clot? Any help will be appreciated. Dick From owner-cardiovascular@net.bio.net Mon Aug 18 23:00:00 1997 From: Andrew Kudrin Newsgroups: bionet.biology.cardiovascular Subject: Diabetes mellitus Date: Tue, 19 Aug 1997 14:30:41 +0400 Organization: GlasNet Lines: 55 Sender: mvl@glas.apc.org Message-ID: <33F975D1.60F3@glasnet.ru> Reply-To: ventraf@glasnet.ru NNTP-Posting-Host: tiger.glas.apc.org Mime-Version: 1.0 Content-Type: text/plain; charset=koi8-r Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 3.02Gold (Win95; I) Path: biosci!bloom-beacon.mit.edu!spool.mu.edu!uwm.edu!vixen.cso.uiuc.edu!news2.chicago.cic.net!iagnet.net!199.60.229.3!newsfeed.direct.ca!newsfeed.dacom.co.kr!newsfeed.kornet.nm.kr!news-stock.gsl.net!gsl-penn-ns.gsl.net!news.gsl.net!gip.net!news.rosprint.net!news.glas.apc.org!usenet "Stelf-Line" Attention - Diabetes Mellitus! Improve the Life Quality! Diabetes mellitus is one of the most widespread chronic diseases. The Moscow Scientific Research Institute of Transplantation and Artificial Organs has elaborated and have been using an original method for treatment diabetes mellitus, which consists of getting and transplantation to a patient active culture of basofile cells of the pancreas. Medical effect duration of transplantation is in average I year. In fact, insulin requirement is decreasing by 20-30% during a year. Diabetes mellitus repeated complications don't mare progress and even partially are cured, the sight is improving, legs pain getting less, disposition to hypoglycemic conditions development disappeared. The culture is injected through a thick needle under topical anesthesia to the restus abdominis. The long admission is not needed. To Doctors-specialists in this Field The Moscow Scientific Research Institute of Transplantation and Artificial Organs has elaborated and have been using an original method for treatment diabetes mellitus. Which consists of getting and transplantation to a patient active culture of basophile cells of the pancreas. The culture has higher insulin productive activity and lower immunactivity. Immunosupression is not used. Since 1994 in Russia, USA and other countries around 1000 the cells culture transplantation's have been done, which were produced by the Moscow Scientific Research Institute of Transplantation and Artificial Organs. The main clinical results consist in disease diabetes mellitus stabilization, reduction the insulin requirement, late diabetes mellitus complications regress. The culture is injected through a thick needle under topical anesthesia to the restus abdominis. The long admission is not needed. For more information: http://www.glasnet.ru/~ventraf/ e-mail: ventraf@glas.apc.org phone: (7-095) 125-7677 fax: (7-095) 124-6376 From owner-cardiovascular@net.bio.net Tue Aug 19 23:00:00 1997 Path: biosci!daresbury!uninett.no!news-feed.inet.tele.dk!Cabal.CESspool!bofh.vszbr.cz!news.maxwell.syr.edu!howland.erols.net!news-peer.gsl.net!news.gsl.net!gip.net!news.he.net!news.reference.com!not-for-mail From: luisgong272@cantv.net Newsgroups: bionet.biology.cardiovascular Subject: We would like to hear from you... Date: 20 Aug 1997 03:24:17 GMT Organization: Reference.Com Posting Service Lines: 29 Message-ID: <5tdo11$ev2$1@orthanc.reference.com> NNTP-Posting-Host: shadowfax.reference.com Originator: panuser@reference.com () Prontomedica, C.A. is a Venezuelan manufacturer of catheters and tubes, looking for importers in other countries. We make medical products of the highest quality at very competitive prices. We have in the past exported to Portugal, Tunis, Germany, Greece, Malaysia, Korea, Central and South America. If you wish to explore a business relationship with us, you can contact us in any of the following ways: Carlos Leguizamon, President Email: catheters@prontomedica.com Web: http://www.prontomedica.com Phone: +582-22-5943 / 21-9543 Fax: +582-22-8324 Thank you. P.S. I (Luis Gonzalez), the sender of this Email, am only a consultant for Prontomedica. Please direct all your inquiries directly to Prontomedica at the address listed above. -- Posted using Reference.COM http://www.reference.com Browse, Search and Post Usenet and Mailing list Archive and Catalog. InReference, Inc. accepts no responsibility for the content of this posting. From owner-cardiovascular@net.bio.net Tue Aug 19 23:00:00 1997 From: jfljsdlfjds@jfasjdflsadjfsd.com Subject: Pamela & Tommy Lee's Secret Sex Tape Newsgroups: bionet.biology.cardiovascular NNTP-Posting-Host: ppp10225.la.inreach.net Message-ID: <33fb6040.0@news.inreach.com> Date: 20 Aug 97 21:23:12 GMT Lines: 21 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!infeed1.internetmci.com!newsfeed.internetmci.com!206.229.87.25!news-peer.sprintlink.net!news-sea-19.sprintlink.net!news-in-west.sprintlink.net!news.sprintlink.net!Sprint!208.25.48.5!news.inreach.com!ppp10225.la.inreach.net DON'T BE FOOLED BY IMITATIONS There is only one Pam & Tommy Sex Tape and it is available here for a limited time only. Others may claim to have it for sale but this is the only Hard Core Copyrighten version in existence. See them bare their soles and bodies in public places, but observe closely, a very private blend of love and sex that they thought the public would never see. Visit: http://www.pamsex.com http://www.pamsex.com From owner-cardiovascular@net.bio.net Tue Aug 19 23:00:00 1997 From: lasjkf939@kjflasjfds.com Subject: Pamela Lee's Secret Sex Video Newsgroups: bionet.biology.cardiovascular NNTP-Posting-Host: ppp11051.la.inreach.net Message-ID: <33fb705d.0@news.inreach.com> Date: 20 Aug 97 22:31:57 GMT Lines: 17 Path: biosci!news.Stanford.EDU!su-news-hub1.bbnplanet.com!news.bbnplanet.com!newsfeed.direct.ca!news-sea-19.sprintlink.net!news-in-west.sprintlink.net!news.sprintlink.net!Sprint!208.25.48.5!news.inreach.com!ppp11051.la.inreach.net Watch Babewatch Star Pamela Anderson Lee and Husband Tommy Lee's Secret Sex tape that is from there Malibu House. This tape is the only orignal copyrighten tape in existest that shows Pamela and Tommy Bare all. Don't be fooled by others, this the one and only orignal tape around. Visit: http://www.pamsex.com From owner-cardiovascular@net.bio.net Wed Aug 20 23:00:00 1997 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!infeed1.internetmci.com!206.229.87.25!news-peer.sprintlink.net!news.sprintlink.net!Sprint!news.maxwell.syr.edu!infeed2.internetmci.com!newsfeed.internetmci.com!205.138.41.4!tir.com!not-for-mail From: Randolph O'Dell Newsgroups: bionet.biology.cardiovascular Subject: info Date: Wed, 20 Aug 1997 22:26:07 -0400 Organization: The Internet Ramp Lines: 2 Message-ID: <33FBA73E.6FB3EAF2@tir.com> NNTP-Posting-Host: pon52.tir.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 4.01 [en] (Win95; I) X-Priority: 3 (Normal) From owner-cardiovascular@net.bio.net Thu Aug 21 23:00:00 1997 Path: biosci!bloom-beacon.mit.edu!panix!howland.erols.net!europa.clark.net!168.143.0.2!news.clark.net!usenet From: "Mark Bates" Newsgroups: bionet.biology.cardiovascular Subject: Sharing Information Date: 22 Aug 1997 01:18:12 GMT Organization: Clark Internet Services, Inc. Lines: 3 Message-ID: <01bcaea8$96e107c0$bf098fa8@mark> NNTP-Posting-Host: omega.clark.net Mime-Version: 1.0 Content-Type: TEXT/PLAIN; charset=ISO-8859-1 Content-Transfer-Encoding: 8bit X-Newsreader: Microsoft Internet News 4.70.1161 If you are a Vascular Technologist and are interested in sharing clinical information, please contact me. From owner-cardiovascular@net.bio.net Fri Aug 22 23:00:00 1997 Path: biosci!internet!biosci!not-for-mail From: biohelp (BIOSCI Administrator) Newsgroups: bionet.biology.cardiovascular Subject: BIOSCI/bionet miniFAQ & Fundraiser Date: 23 Aug 1997 02:00:05 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 233 Sender: daemon@net.bio.net Distribution: world Message-ID: <199708230900.CAA15518@net.bio.net> NNTP-Posting-Host: net.bio.net (LAST REVISION: 30-JUL-95) This BIOSCI "miniFAQ" is designed to answer the questions that come up the *most frequently*. The main BIOSCI FAQ (Frequently Asked Questions) is accessible on the World Wide Web at URL http://www.bio.net/. If you can not find an answer to your question in this or other documentation, the BIOSCI technical support staff answers e-mail queries sent to biosci-help@net.bio.net We can only answer questions about the use of the newsgroups and mailing lists. We unfortunately do not have the staff to do Internet information searches or answer scientific questions. Please post those to the appropriate BIOSCI/bionet newsgroups. Contents: -------- 0) BIOSCI NEEDS YOUR SUPPORT!! 1) Using the WWW to access the BIOSCI/bionet newsgroups. 2) What to do about "spams," i.e., junk mail, ads, etc. 3) Examples of subscribing and unsubscribing to the mailing lists. 4) The BIOSCI user address and research interest directory. 0) BIOSCI NEEDS YOUR SUPPORT!! ------------------------------ BIOSCI's government funding has been expended, and we are now operating solely from advertising revenue that we have raised from our Web site at http://www.bio.net/. We need just a few minutes of your time to help us serve you. You can do two important things which will take very little time for you individually and will immensely help us continue to help you. First, please use our WWW system at http://www.bio.net/ to access the archives. You can post or reply to messages via your Web browser as described in item #1 below. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. 1) Using the WWW to access the BIOSCI/bionet newsgroups. -------------------------------------------------------- As of 10 December 1995, all BIOSCI/bionet full newsgroups are accessible through the World Wide Web (WWW) at URL http://www.bio.net. One can read and reply publicly or privately to both recent postings and archived messages through one's Web browser if it is configured properly to send e-mail. Each newsgroup is equipped with its own WAIS index. The main BIOSCI home page also has access to the BIO-JOURNALS Table of Contents database WAIS index and the BIOSCI user address database described in another item further below. 2) What to do about "spams," i.e., junk mail, ads, etc. ------------------------------------------------------- BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups), mailing lists, and a hypermail archive at URL http://www.bio.net/. The same postings are distributed on all media (except for a small number of mailing-list-only groups at net.bio.net). Unfortunately it is becoming a despicable practice on the Internet (by a few people out to make a fast buck) to do automated mass postings to thousands of newsgroups and mailing lists. These attempts to grab free advertising are refered to as "spams" in the usual, somewhat boneheaded, net terminology. USENET is more susceptible to this practice, and many spams originate on the USENET groups and then are passed on to the mailing lists. However, spammers also get lists of mailing addresses and hit these too, so neither medium is immune. What should you do personally if you get junk mail? --------------------------------------------------- Just delete it and move on without reading it further. Filing a protest is becoming increasingly useless because spammers are often disguising the addresses where the messages are sent from. Unless you really understand Internet mail systems, your attempt at protest by sending replies to the message will often end up being sent to the address of an innocent person that the spammer is victimizing. What can BIOSCI/bionet do to protect its newsgroups? ---------------------------------------------------- The only solution currently available is to moderate the newsgroup. If this newsgroup is already moderated, then you are in good shape. Moderation protects the USENET distribution from about 95% of the spams that are being sent to date and protects the mailing lists completely. Moderation means, however, that someone has to take the time to review each message before it goes out. We have set up software here that simply allows the moderator to forward to an address at net.bio.net messages that (s)he wishes to have distributed. This takes no more time than that needed to read the message and pass it on, say about 1 min. per message. Most newsgroups currently have a discussion leader who is responsible for their newsgroup. The discussions leaders and their e-mail addresses are listed in the BIOSCI Information Sheet which is available on the Web at http://www.bio.net/. If a newsgroup is being hit with too many junk postings, please contact the discussion leader for that group and see if there is interest in moderating the group. Please do not assume that by simply posting a complaint to the newsgroup itself, anyone on the BIOSCI staff will act on your complaint. With close to 100 newsgroups to run, the BIOSCI staff has to rely on the discussion leaders of each newsgroup to report problems directly to us at biosci-help@net.bio.net. We will moderate any of our newsgroups if the discussion leader tells us that the readership of the group wishes to do so and if a moderator is willing to do the work. For most BIOSCI/bionet groups, this entails only a few minutes of work each day. Moderating a newsgroup will resolve probably 95% of the junk postings on the USENET distribution. Unfortunately there are easy ways for determined spammers to override the moderation mechanism on USENET, but we can protect our e-mail subscribers from unwanted postings if the newsgroup is moderated. You can also access our newsgroups over the WWW at URL http://www.bio.net. While this Web interface will not stop spammers from trying to post to the groups, this will give you yet another way, besides using USENET news, to keep the junk out of your personal mail files. For those of you with local USENET news systems, the Web interface will also give you faster access to new newsgroups and recent postings. 3) Examples of subscribing and unsubscribing to the mailing lists. ------------------------------------------------------------------ PLEASE NOTE: The BIOSCI management does NOT act on subscription/unsubscription requests that are posted improperly to the newsgroups and mailing lists. People who do this only bother everyone on the lists to no avail. Please be sure to follow the proper procedures below. Gory details are in the BIOSCI Information sheets on the Web at http://www.bio.net. Below we give an example utilizing the METHODS-AND-REAGENTS list at both of our two BIOSCI sites: Users in the Americas and Pacific Rim countries who use the BIOSCI ------------------------------------------------------------------ node at computer net.bio.net: ---------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@net.bio.net. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to biosci-server@net.bio.net. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Do NOT put your e-mail address or other text on these lines. The server only allows you to cancel your subscription if the address on your mail header matches the address on our mailing list. Please ask for help at biosci-help@net.bio.net if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. Users in Europe, Africa, and Central Asia who use the BIOSCI node at -------------------------------------------------------------------- computer daresbury.ac.uk (also known as dl.ac.uk): ------------------------------------------------- To subscribe and unsubscribe to/from the BIOSCI lists, you need to specify the full USENET newsgroup name with "bionet-news." prepended. The USENET newsgroup names are listed in the BIOSCI Information sheet on the Web at http://www.bio.net/. For the METHODS-AND-REAGENTS list the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the appropriate commands are sub bionet-news.bionet.molbio.methds-reagnts unsub bionet-news.bionet.molbio.methds-reagnts These commands are included in a message addressed to mxt@dl.ac.uk, NOT to the newsgroup mailing addresses. As usual, include the text in the body of the message as text on the Subject: line is ignored. To unsubscribe from all the lists at the UK node, use unsub bionet-news Please note that if the address in the list is different than the one in your mail message header, you will not be able to unsubscribe by this method. If you have problems, please mail biosci@daresbury.ac.uk. 4) The BIOSCI user address and research interest directory. ----------------------------------------------------------- Please take this opportunity to add your name, address, and research interest information to the BIOSCI User Address Database if you have not already done so. You can fill out the address form directly through our Web page at URL http://www.bio.net/adrform.html. The address database is reindexed nightly for WWW access (the URL is http://www.bio.net/). If you are not directly on the Internet but can reach it by e-mail, please use our waismail server to access the user directory. waismail use is described above. You can also request a user address form by e-mail from biosci-help@net.bio.net. Please check your database entry from time-to-time to see if your address information is still up-to-date. Because of our limited personnel resources, we ask that you resubmit a *complete* form to revise your entry; we only replace complete entries and do not have resources to edit old forms. From owner-cardiovascular@net.bio.net Sat Aug 23 23:00:00 1997 Path: biosci!daresbury!uninett.no!Norway.EU.net!EU.net!infeed1.internetmci.com!newsfeed.internetmci.com!152.163.199.19!portc03.blue.aol.com!newstf02.news.aol.com!audrey02.news.aol.com!not-for-mail From: huntpharm@aol.com (Huntpharm) Newsgroups: bionet.biology.cardiovascular Subject: US-MD-JOB OPPORTUNITY IN PROJECT MANAGEMENT Date: 24 Aug 1997 13:08:37 GMT Lines: 20 Message-ID: <19970824130801.JAA24487@ladder02.news.aol.com> NNTP-Posting-Host: ladder02.news.aol.com X-Admin: news@aol.com Organization: AOL http://www.aol.com I am looking for a Project Manager in drug development from the pharmaceutical or bio-tech industry. Responsibilities include generating and maintaining product-specific development plans and project oversight in order to maximize the effective use of company-wide resources in meeting corporate objectives. This person will serve as the primary resource for communicating information relating to the status of product-specific development activities, interrnally and externally, and provide creative development options to team members for consideration in meeting short and long term product specific corporate goals and objectives. The selected candidate will have 1+ years experience and possess a B.S., M.S. or PhD degree in a scientific discipline and in depth knowledge of the drug development process within the pharmaceutical industry. We are a leading biotech firm with research facilities in Baltimore, Maryland and can provide excellent benefits (health insurance, dental, and vision plan, stock options, bonus program, paid vactation and more). A high impact, high profile position with excellent opportunity for advancement. Please contact Scott Shanes by phone at 609-584-8733 Ext. 218, fax CV and cover letter to 609-584-9575 or E-Mail to sis@dmc10.com or sis@diedremoire.com From owner-cardiovascular@net.bio.net Tue Aug 26 23:00:00 1997 Path: biosci!lhc.nlm.nih.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!infeed1.internetmci.com!newsfeed.internetmci.com!194.72.7.126!news-peer.bt.net!btnet-feed2!btnet!peer1.news.dircon.net!newsserver.dircon.co.uk!not-for-mail From: Newsgroups: alt.support-heart,bionet.biology.cardiovascular,fj.sci.medical,misc.education.medical,sci.med.cardiology,tnn.medical,ucd.talk.medical.entomology Subject: Re: the use of femoral arterial compression devices to promote haemostasis. Date: 27 Aug 1997 23:14:01 GMT Organization: via Direct Connection News service Lines: 17 Message-ID: <01bcb33e$261e5e80$342670c2@default> NNTP-Posting-Host: du4-052.pool.dircon.co.uk X-Newsreader: Microsoft Internet News 4.70.1157 I am a registered nurse currently working on a cardiology ward at St. Thomas' Hospital, London. My work involves the pre and post operative care of patients undergoing coronary angiography, percutaneous transluminal coronary angioplasty and coronary rotablation. Untill recently the policy on femoral arterial sheath removal was that the Senior House Officer on call for the ward would remove the sheath and manually press on the wound untill haemostasis occurred. Now there is a move to a) have the doctor use a femoral compression device such as the femostop, or b) have the nurses on the ward remove the sheaths. I have attempted to research the efficacy of femostops without any real success. I have one research article which states the use of such devices leaves the patient open to a much higher risk of haematoma and femoral arterial emboli. If anyone has any relevant literature I would be very grateful if they could contact me. With thanks in anticipation, Martin Jennis. From owner-cardiovascular@net.bio.net Tue Aug 26 23:00:00 1997 Path: biosci!bloom-beacon.mit.edu!ai-lab!netnews.com!europa.clark.net!4.1.16.34!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!news-peer.sprintlink.net!news-east.sprintlink.net!news-dc-26.sprintlink.net!news-dc-2.sprintlink.net!news-dc-9.sprintlink.net!news.sprintlink.net!Sprint!swbell!not-for-mail From: "frazzled" Newsgroups: bionet.biology.cardiovascular Subject: congestive heart failure Date: 27 Aug 1997 21:30:14 GMT Organization: Southwestern Bell Internet Services, Richardson, TX Lines: 22 Message-ID: <01bcb330$1d2cab00$3000c1cf@rot> NNTP-Posting-Host: ppp-207-193-0-48.kscymo.swbell.net X-Newsreader: Microsoft Internet News 4.70.1160 Hi, http://www.geocities.com/Heartland/Hills/2571/jonsplace.htm This is a support and information forum for those with congestive heart failure and those who's loved one has CHF. Message boards, chat room, medical studies, drug trials, carefully selected WWW links and CHF from patients' perspectives. Also includes information on and discussion of minerals, vitamins, nutrients, alternative therapies, surgeries and doctors. Also includes up to the minute info on the Batista procedure from Dr. P. McCarthy, who has done more ventricular remodelings than any other USA surgeon. Thank you, Dr. McCarthy. I have CHF (EF=13%), and maintain the site. Everyone interested in CHF is welcome, including doctors, nurses and other medical professionals, but this is a non-commercial site and is geared to people with the condition or those whose loved one has CHF. A site index is located at the URL in my signature. Thanks, -- Jon -- MrBooBoo@msn.com http://www.geocities.com/Heartland/Hills/2571/jonsitemap.htm From owner-cardiovascular@net.bio.net Tue Aug 26 23:00:00 1997 Path: biosci!daresbury!uninett.no!Norway.EU.net!EU.net!howland.erols.net!news-peer.gsl.net!news.gsl.net!gip.net!huron.eel.ufl.edu!usenet.eel.ufl.edu!usenet.cise.ufl.edu!usenet.ufl.edu!usenet From: "Mark S. Wills" Newsgroups: bionet.biology.cardiovascular Subject: Balloon angioplasty of pulmonary artery Date: 27 Aug 1997 15:35:13 GMT Organization: University of Florida Lines: 5 Message-ID: <01bcb2fe$9a5c2a60$d039e380@willsms.fgp.ufl.edu> NNTP-Posting-Host: s057n208.fgp.ufl.edu X-Newsreader: Microsoft Internet News 4.70.1161 Any suggestions on how to most appropriately code a balloon angioplasty of pulmonary artery? Any help would be most appreciated. Thanks. Mark Wills UF Faculty Group Practice From owner-cardiovascular@net.bio.net Wed Aug 27 23:00:00 1997 Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!dispatch.news.demon.net!demon!bullseye.news.demon.net!demon!newsgate.unisource.nl!News.Amsterdam.UnisourceCS!newsfeed.mad.ibernet.es!newsfeed.bcn.ibernet.es!news.mad.ibernet.es!not-for-mail From: "ELADIO RAMOS GONZÁLEZ-SERNA" Newsgroups: bionet.biology.cardiovascular Subject: hypertension Date: 28 Aug 1997 01:20:03 GMT Organization: RGS PRODUCCIONES Message-ID: <01bcb34f$f7170300$28534dc3@default> NNTP-Posting-Host: ppp139.85.redestb.es X-Newsreader: Microsoft Internet News 4.70.1161 Lines: 5 I am interested in newsgroups on research in hypertension ¿Are there any one? If not, ¿How can I start one? ¿Are you also interested? Send me a message. eramos@farmanet.com From owner-cardiovascular@net.bio.net Wed Aug 27 23:00:00 1997 Path: biosci!bloom-beacon.mit.edu!ai-lab!netnews.com!news2.euro.net!bullseye.news.demon.net!demon!newsgate.unisource.nl!News.Amsterdam.UnisourceCS!newsfeed.mad.ibernet.es!news.mad.ibernet.es!not-for-mail From: "ELADIO RAMOS GONZÁLEZ-SERNA" Newsgroups: bionet.biology.cardiovascular Subject: hypertension research newsgroups Date: 28 Aug 1997 01:41:20 GMT Organization: RGS PRODUCCIONES Message-ID: <01bcb352$e5400700$8b554dc3@default> NNTP-Posting-Host: ppp173.89.redestb.es X-Newsreader: Microsoft Internet News 4.70.1161 Lines: 5 I am interested in newsgroups on research on hypertension. Are there any? If not, how can I start one? If you are interested too, please send to me a message eramos@farmanet.com From owner-cardiovascular@net.bio.net Fri Aug 29 23:00:00 1997 Path: biosci!fcs280s.ncifcrf.gov!cpk-news-feed4.bbnplanet.com!cpk-news-feed1.bbnplanet.com!cpk-news-hub1.bbnplanet.com!news.bbnplanet.com!ais.net!infeed1.internetmci.com!newsfeed.internetmci.com!192.48.96.126!in2.uu.net!208.202.14.37!news.icanect.net!not-for-mail From: barrys@icanect.net (Barry Sohn) Newsgroups: bionet.biology.cardiovascular Subject: Heart bypass surgery - description please Date: Sat, 30 Aug 1997 04:40:38 GMT Organization: Icanect Lines: 12 Message-ID: <3407a1c3.7061592@news.icanect.net> NNTP-Posting-Host: 206.142.167.201 X-Newsreader: Forte Free Agent 1.1/32.230 Could anyone direct me to a web site or other reference where I could find a description (and possibly photos) of heart bypass surgery? I'm also seeking a description, for the family of the patient, of what we would expect to see when visiting the ICU after the surgery. Additionally, are their online support groups for patients and/or family. AOL and Compuserve sources are ok as well. Thank you, Barry Sohn barrys@icanect.net From owner-cardiovascular@net.bio.net Fri Aug 29 23:00:00 1997 Path: biosci!agate!howland.erols.net!news.apfel.de!nntp.uio.no!mn5.swip.net!news From: md43643@dredd.swipnet.se Newsgroups: sci.med.physics,bionet.biology.cardiovascular,sci.med.cardiology,alt.health.cfs Subject: Need a diagnose Date: Thu, 28 Aug 1997 20:28:53 GMT Organization: - Lines: 47 Message-ID: <3405de88.46001398@nntpserver.swip.net> NNTP-Posting-Host: dialup148-2-14.swipnet.se NNTP-Posting-User: s-258154 X-Newsreader: Forte Free Agent 1.1/32.230 I´m a white male 37 years old. Married and have a healthy kid. Work as CEO. My problem is that my condition is extremly low. I can´t excercise if I do little to long walking or slowly running I will be very ill, shaky, dizzy, palpitations, and hyperventilation feel like dying for maybe 30 minutes to hours. The problem dos not occur when I do like lift weight with arms. It seems that it must be some main body exercise. Every time this happen it´s very bad feeling and only way that it not happen is to think before every move I take. It seems that the total summary of step (walking) in a day is connected to the situation when the bad situation occur. Till my age 20 this hasn´t happen, I was doing many sports when I was young and didn´t feel this. After 20 it comes more and more often. Today it´s every time when I do only little short wakling (200 meters). I must take the car everywhere I should go. Somebody must had this experience or heard about anybody who has had the same symptoms. A. What is the diagnose? 1. Can it be some heartfailure (rest ECG is ok, done 4 times, same every time) but they said it was a little small jump in every cycle, but it often is that. I have not done excercise ECG yet or use Holter ECG but will do soon. 2. Can it be some metabolic failure. It seems that when I have lactic acid after move. It happen. And also hot temperature (sun) do it worse. And cold (winter) do it better. 3. Is it "only" psycologic. In my head. 4. Or something else. B. How can I improve my condition without that this bad situations occur? C. Have you heard about any MD who is expert in this area? Please mail your answer to: md43643@dredd.swipnet.se From owner-cardiovascular@net.bio.net Sat Aug 30 23:00:00 1997 From: Andrew Chung Newsgroups: sci.med.physics,bionet.biology.cardiovascular,sci.med.cardiology,alt.health.cfs Subject: Re: Need a diagnose Date: Sun, 31 Aug 1997 13:40:33 -0400 Organization: Emory Medicine Lines: 106 Message-ID: <3409ABF2.DF5A59A6@emory.edu> References: <3405de88.46001398@nntpserver.swip.net> NNTP-Posting-Host: wmb3308-1.cardio.emory.edu Mime-Version: 1.0 Content-Type: multipart/signed; protocol="application/x-pkcs7-signature"; micalg=sha1; boundary="------------msC1F6AD022100427234D7FCFE" X-Mailer: Mozilla 4.01 (Macintosh; I; PPC) X-Priority: 3 (Normal) Path: biosci!agate!nntp.info.ucla.edu!infeed1.internetmci.com!newsfeed.internetmci.com!144.212.95.13!nntprelay.mathworks.com!news.mathworks.com!newsfeed.ecrc.net!news.new-york.net!andromeda.vec.net!cssun.mathcs.emory.edu!news.service.emory.edu!news This is a cryptographically signed message in MIME format. --------------msC1F6AD022100427234D7FCFE Content-Type: text/plain; charset=us-ascii; x-mac-type="54455854"; x-mac-creator="4D4F5353" Content-Transfer-Encoding: 7bit it sounds like you need to work with your primary physician to figure out what is causing your symptoms. what you describe could be cause by problems with either the lungs or heart (or mind). it is too early for a referral to a specialist. -- Andrew Chung Homepage at: http://userwww.service.emory.edu/~achung Mirrored at: http://www.emory.edu/WHSC/MED/HTN/~achung/ --------------msC1F6AD022100427234D7FCFE Content-Type: application/x-pkcs7-signature; name="smime.p7s" Content-Transfer-Encoding: base64 Content-Disposition: attachment; filename="smime.p7s" Content-Description: S/MIME Cryptographic Signature MIIQjQYJKoZIhvcNAQcCoIIQfjCCEHoCAQExCzAJBgUrDgMCGgUAMAsGCSqGSIb3DQEHAaCC DvswggpFMIIJrqADAgECAhAzZ2w25/KxwQwFP23anbXIMA0GCSqGSIb3DQEBBAUAMGIxETAP BgNVBAcTCEludGVybmV0MRcwFQYDVQQKEw5WZXJpU2lnbiwgSW5jLjE0MDIGA1UECxMrVmVy aVNpZ24gQ2xhc3MgMSBDQSAtIEluZGl2aWR1YWwgU3Vic2NyaWJlcjAeFw05NzA4MTEwMDAw MDBaFw05ODAyMTAyMzU5NTlaMIIBDTERMA8GA1UEBxMISW50ZXJuZXQxFzAVBgNVBAoTDlZl cmlTaWduLCBJbmMuMTQwMgYDVQQLEytWZXJpU2lnbiBDbGFzcyAxIENBIC0gSW5kaXZpZHVh bCBTdWJzY3JpYmVyMUYwRAYDVQQLEz13d3cudmVyaXNpZ24uY29tL3JlcG9zaXRvcnkvQ1BT IEluY29ycC4gYnkgUmVmLixMSUFCLkxURChjKTk2MSYwJAYDVQQLEx1EaWdpdGFsIElEIENs YXNzIDEgLSBOZXRzY2FwZTEYMBYGA1UEAxMPQW5kcmV3IEIuIENodW5nMR8wHQYJKoZIhvcN AQkBFhBhY2h1bmdAZW1vcnkuZWR1MFwwDQYJKoZIhvcNAQEBBQADSwAwSAJBALo8aBvsByNw 9KDxVBLtrpf3sG3qAPTUD2M82nMNjl4l0qkQq4OtwFZqIAia94IsRnd6p15oAGFpW/hPO4VV pgkCAwEAAaOCB5EwggeNMAkGA1UdEwQCMAAwggIfBgNVHQMEggIWMIICEjCCAg4wggIKBgtg hkgBhvhFAQcBATCCAfkWggGnVGhpcyBjZXJ0aWZpY2F0ZSBpbmNvcnBvcmF0ZXMgYnkgcmVm ZXJlbmNlLCBhbmQgaXRzIHVzZSBpcyBzdHJpY3RseSBzdWJqZWN0IHRvLCB0aGUgVmVyaVNp Z24gQ2VydGlmaWNhdGlvbiBQcmFjdGljZSBTdGF0ZW1lbnQgKENQUyksIGF2YWlsYWJsZSBh dDogaHR0cHM6Ly93d3cudmVyaXNpZ24uY29tL0NQUzsgYnkgRS1tYWlsIGF0IENQUy1yZXF1 ZXN0c0B2ZXJpc2lnbi5jb207IG9yIGJ5IG1haWwgYXQgVmVyaVNpZ24sIEluYy4sIDI1OTMg Q29hc3QgQXZlLiwgTW91bnRhaW4gVmlldywgQ0EgOTQwNDMgVVNBIFRlbC4gKzEgKDQxNSkg OTYxLTg4MzAgQ29weXJpZ2h0IChjKSAxOTk2IFZlcmlTaWduLCBJbmMuICBBbGwgUmlnaHRz IFJlc2VydmVkLiBDRVJUQUlOIFdBUlJBTlRJRVMgRElTQ0xBSU1FRCBhbmQgTElBQklMSVRZ IExJTUlURUQuoA4GDGCGSAGG+EUBBwEBAaEOBgxghkgBhvhFAQcBAQIwLDAqFihodHRwczov L3d3dy52ZXJpc2lnbi5jb20vcmVwb3NpdG9yeS9DUFMgMBEGCWCGSAGG+EIBAQQEAwIHgDA2 BglghkgBhvhCAQgEKRYnaHR0cHM6Ly93d3cudmVyaXNpZ24uY29tL3JlcG9zaXRvcnkvQ1BT MIIEhwYJYIZIAYb4QgENBIIEeBaCBHRDQVVUSU9OOiBUaGUgQ29tbW9uIE5hbWUgaW4gdGhp cyBDbGFzcyAxIERpZ2l0YWwgCklEIGlzIG5vdCBhdXRoZW50aWNhdGVkIGJ5IFZlcmlTaWdu LiBJdCBtYXkgYmUgdGhlCmhvbGRlcidzIHJlYWwgbmFtZSBvciBhbiBhbGlhcy4gVmVyaVNp Z24gZG9lcyBhdXRoLQplbnRpY2F0ZSB0aGUgZS1tYWlsIGFkZHJlc3Mgb2YgdGhlIGhvbGRl ci4KClRoaXMgY2VydGlmaWNhdGUgaW5jb3Jwb3JhdGVzIGJ5IHJlZmVyZW5jZSwgYW5kIApp dHMgdXNlIGlzIHN0cmljdGx5IHN1YmplY3QgdG8sIHRoZSBWZXJpU2lnbiAKQ2VydGlmaWNh dGlvbiBQcmFjdGljZSBTdGF0ZW1lbnQgKENQUyksIGF2YWlsYWJsZQppbiB0aGUgVmVyaVNp Z24gcmVwb3NpdG9yeSBhdDogCmh0dHBzOi8vd3d3LnZlcmlzaWduLmNvbTsgYnkgRS1tYWls IGF0CkNQUy1yZXF1ZXN0c0B2ZXJpc2lnbi5jb207IG9yIGJ5IG1haWwgYXQgVmVyaVNpZ24s CkluYy4sIDI1OTMgQ29hc3QgQXZlLiwgTW91bnRhaW4gVmlldywgQ0EgOTQwNDMgVVNBCgpD b3B5cmlnaHQgKGMpMTk5NiBWZXJpU2lnbiwgSW5jLiAgQWxsIFJpZ2h0cyAKUmVzZXJ2ZWQu IENFUlRBSU4gV0FSUkFOVElFUyBESVNDTEFJTUVEIEFORCAKTElBQklMSVRZIExJTUlURUQu CgpXQVJOSU5HOiBUSEUgVVNFIE9GIFRISVMgQ0VSVElGSUNBVEUgSVMgU1RSSUNUTFkKU1VC SkVDVCBUTyBUSEUgVkVSSVNJR04gQ0VSVElGSUNBVElPTiBQUkFDVElDRQpTVEFURU1FTlQu ICBUSEUgSVNTVUlORyBBVVRIT1JJVFkgRElTQ0xBSU1TIENFUlRBSU4KSU1QTElFRCBBTkQg RVhQUkVTUyBXQVJSQU5USUVTLCBJTkNMVURJTkcgV0FSUkFOVElFUwpPRiBNRVJDSEFOVEFC SUxJVFkgT1IgRklUTkVTUyBGT1IgQSBQQVJUSUNVTEFSClBVUlBPU0UsIEFORCBXSUxMIE5P VCBCRSBMSUFCTEUgRk9SIENPTlNFUVVFTlRJQUwsClBVTklUSVZFLCBBTkQgQ0VSVEFJTiBP VEhFUiBEQU1BR0VTLiBTRUUgVEhFIENQUwpGT1IgREVUQUlMUy4KCkNvbnRlbnRzIG9mIHRo ZSBWZXJpU2lnbiByZWdpc3RlcmVkCm5vbnZlcmlmaWVkU3ViamVjdEF0dHJpYnV0ZXMgZXh0 ZW5zaW9uIHZhbHVlIHNoYWxsIApub3QgYmUgY29uc2lkZXJlZCBhcyBhY2N1cmF0ZSBpbmZv cm1hdGlvbiB2YWxpZGF0ZWQgCmJ5IHRoZSBJQS4wgYYGCmCGSAGG+EUBBgMEeBZ2ZDQ2NTJi ZDYzZjIwNDcwMjkyOTg3NjNjOWQyZjI3NTA2OWM3MzU5YmVkMWIwNTlkYTc1YmM0YmM5NzAx NzQ3ZGE1ZDNmMjE0MWJlYWRiMmJkMmU4OTIxNWFkNjhmM2Q1MTE0OTk5YTNiYzQ0ZjhmM2Vh NDU2NDANBgkqhkiG9w0BAQQFAAOBgQA62fpNRrM10RMT+2r0dA7TALuKQqc9oR5e7LlOcUui uDX929Zvjz3VDIjyZEL5DNet4TqLHfzPNLjLqu/d82QAYO0NR5sQrVAVh8kpWZyDkO7X5rMz /4jH0MSTBYJsrTARx31SvYrVEZozBAK2AlhePFkNvISNhbEWGyYmbk/dqTCCAnkwggHioAMC AQICEFIfNR3ycH4AK77KWYcE1TkwDQYJKoZIhvcNAQECBQAwXzELMAkGA1UEBhMCVVMxFzAV BgNVBAoTDlZlcmlTaWduLCBJbmMuMTcwNQYDVQQLEy5DbGFzcyAxIFB1YmxpYyBQcmltYXJ5 IENlcnRpZmljYXRpb24gQXV0aG9yaXR5MB4XDTk2MDYyNzAwMDAwMFoXDTk5MDYyNzIzNTk1 OVowYjERMA8GA1UEBxMISW50ZXJuZXQxFzAVBgNVBAoTDlZlcmlTaWduLCBJbmMuMTQwMgYD VQQLEytWZXJpU2lnbiBDbGFzcyAxIENBIC0gSW5kaXZpZHVhbCBTdWJzY3JpYmVyMIGfMA0G CSqGSIb3DQEBAQUAA4GNADCBiQKBgQC2FKbPTdAFDdjKI9BvqrQpkmOOLPhvltcunXZLEbE2 jVfJw/0cxrr+Hgi6M8qV6r7jW80GqLd5HUQq7XPysVKDaBBwZJHXPmv5912dFEObbpdFmIFH 0S3L3bty10w/cariQPJUObwW7s987LrbP2wqsxaxhhKdrpM01bjV0Pc+qQIDAQABozMwMTAP BgNVHRMECDAGAQH/AgEBMAsGA1UdDwQEAwIBBjARBglghkgBhvhCAQEEBAMCAQYwDQYJKoZI hvcNAQECBQADgYEAwfr3AudXyhF1xpwM+it3T4dFFzvj0sHaD1g5jq6VmQOhqKE4/nmakxcL l4Y5x8poNGa7x4hF9sgMBe6+lyXv4NRu5H+ddlzOfboUoq4Ln/tnW0ilZyWvGWSI9nLYKSeq NxJqsSivJ4MYZWyN7UCeTcR4qIbs6SxQv6b5DduwpkowggIxMIIBmgIFAqQAAAEwDQYJKoZI hvcNAQECBQAwXzELMAkGA1UEBhMCVVMxFzAVBgNVBAoTDlZlcmlTaWduLCBJbmMuMTcwNQYD VQQLEy5DbGFzcyAxIFB1YmxpYyBQcmltYXJ5IENlcnRpZmljYXRpb24gQXV0aG9yaXR5MB4X DTk2MDEyOTAwMDAwMFoXDTk5MTIzMTIzNTk1OVowXzELMAkGA1UEBhMCVVMxFzAVBgNVBAoT DlZlcmlTaWduLCBJbmMuMTcwNQYDVQQLEy5DbGFzcyAxIFB1YmxpYyBQcmltYXJ5IENlcnRp ZmljYXRpb24gQXV0aG9yaXR5MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDlGb9to1Zh LZlIcfZn3rmN67eehoAKkQ76OCWvRoiC5XOooJskXQ0fzGVuDLDQVoQYh5oGmxChc9+0WDlr bsH2FdWoqD+qEgaNMax/sDTXjzRniAnNFBHiTkVWaR94AoDa3EeRKbs2yWNcxeDXLYd7obcy sHswuiovMaruo2fa2wIDAQABMA0GCSqGSIb3DQEBAgUAA4GBAFJzuppV3Nw/gn2wkJhiKoJM dgBuJT3VwglwVwEMD3cfGKH7HGAOoHU7SSFB/qdcLUxCSdP/KNiM6p3+yQfid4JTI95V885E k/r6TL3KNvNbZrKeyPIMXl7UobQhCTPKO1n8ksI4/K3ZliTgLfqjKfUzaHhOtLyfaTXiqJiU czvEMYIBWjCCAVYCAQEwdjBiMREwDwYDVQQHEwhJbnRlcm5ldDEXMBUGA1UEChMOVmVyaVNp Z24sIEluYy4xNDAyBgNVBAsTK1ZlcmlTaWduIENsYXNzIDEgQ0EgLSBJbmRpdmlkdWFsIFN1 YnNjcmliZXICEDNnbDbn8rHBDAU/bdqdtcgwCQYFKw4DAhoFAKB9MBgGCSqGSIb3DQEJAzEL BgkqhkiG9w0BBwEwHAYJKoZIhvcNAQkFMQ8XDTk3MDgzMTE4NDAzM1owHgYJKoZIhvcNAQkP MREwDzANBggqhkiG9w0DAgIBKDAjBgkqhkiG9w0BCQQxFgQUwp3I+NG2wWu4pwv/XHCfRjuk I+AwDQYJKoZIhvcNAQEBBQAEQBHczMzGbD05SHiYc6TI6FeVkjuQfym1v/ATRl04and+RTav prInz3NSnmpNkfqwN2Q7qxhq0KHe6FcPCJL//nw= --------------msC1F6AD022100427234D7FCFE-- From owner-cardiovascular@net.bio.net Sun Aug 31 23:00:00 1997 Path: biosci!agate!howland.erols.net!infeed1.internetmci.com!newsfeed.internetmci.com!152.163.199.19!portc03.blue.aol.com!newstf02.news.aol.com!audrey02.news.aol.com!not-for-mail From: janczek@aol.com (JanCzek) Newsgroups: bionet.biology.cardiovascular Subject: Re: Biology related web sites wanted Date: 1 Sep 1997 19:24:05 GMT Lines: 4 Message-ID: <19970901192401.PAA22672@ladder02.news.aol.com> NNTP-Posting-Host: ladder02.news.aol.com X-Admin: news@aol.com Organization: AOL http://www.aol.com References: <01bcac8a$3c4a5520$064295c1@default> SnewsLanguage: English You may include interesting www catalog of Biological Research Equipment from Columbus Instruments: WWW.COLINST.COM and WWW.RESPIROMETER.COM jan czekajewski